Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Acromegaly × Octreotide × Clear all

Phase

Phase 4 2 Phase NA 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Gastrointestinal 1 Endocrine 1

Conditions

Zollinger-Ellison Syndrome 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Somatostatinoma 1 Paraganglioma 1 Insulinoma 1 Glucagonoma 1 Gastro-enteropancreatic neuroendocrine tumor 1 Carcinoma, Merkel Cell 1 Carcinoma, Medullary 1 Carcinoid Tumor 1 Adenoma, Islet Cell 1 Acromegaly 1

Interventions

pasireotide 1 lanreotide 1 Octreotide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05364944 2025-11-17

OXTEND-01

Debiopharm International SA

Phase 1 Terminated

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Acromegaly

Data powered by HemOnc (CC BY 4.0) Colophon ⚡